Difference between revisions of "IHE Domain Coordination Committee Teleconference Minutes 2011-11-08"

From IHE Wiki
Jump to navigation Jump to search
Line 33: Line 33:
1. [[Domain Milestone Dates]]   
1. [[Domain Milestone Dates]]   
No new milestone dates reported.
2. Domain [[Board Reports]]  (10 min - Karen Witting)
2. Domain [[Board Reports]]  (10 min - Karen Witting)

Revision as of 11:51, 8 November 2011


  • Ken Fuchs
  • Joan McMillen
  • Karen Witting
  • LaVerne Palmer
  • Mary Jungers
  • Mary Kennedy
  • Simon Litellier(Pharmacy)
  • Sondra Renly (lab tc)
  • Antje Schroeder
  • Celina Roth
  • Geoff Pascoe
  • Kevin O'Donnell
  • Sidrah Abdul
  • Teri Schippel Schmidt
  • Jim St. Clair
  • Did Davis
  • La Shawn Edwards

General Committee Business

1. Roll Call see Roster

2. Approval of October 25 Minutes (Will be approved on next call November 22nd)

3. New Business: from Future Agenda Topics Page (deferred)

4. Review Action Items List (deferred)

Domain Announcements

  • reminder - follow the link above for simple templates for announcements

1. Domain Milestone Dates

No new milestone dates reported.

2. Domain Board Reports (10 min - Karen Witting)

  • Simone and Jacquline S. were available on call to answer questions
  • Requested Changes to Pharmacy Board Report:
  • Pharmacy wiki should use wiki Process Template to indicate key Milestones (See Radiology as example)
  • Profile descriptions on wiki are clearer than the ones used in the Board Report (change)
  • What are the transport mechanisms for the Profiles PRE, PADV, and DIS? add to report in Notes column.
  • Is there an active plan to recruit more vendors?
  • Expound upon "Supply Chain" in final section of the report.
  • Pharm Report will be presented to IHE Board at RSNA meeting on Nov 30th (also webex available); updated report provided one week prior
  • Juergen will attempt to attend IHE Board calls more regularly (help monthly) Approved for one face-to-face meeting annually (RSNA or HIMSS).
  • Motion: Kevin/ Second: Karen; no objections or absentions; unanimously approved with requested changes

Domain Coordination Issues

  • Cross-Domain Strategic Planning Work Group (update - Karen Witting - 5 min)
  • responses from all Domains due November 21st, 2011.
  • There was significant confusion about the format of the report and/or existence of a template. There is NO template or required format or mechanism. Each domain is free to chose method, e.g., wiki or Word file.
  • Instructions were sent out in an email from Chris Carr on Oct 3rd.
  • Profile Maturity Metric Proposal (Kevin O'Donnell - 15 min)
  • Kevin suggests that people take a look and if there are any comments/suggestions please let him know.
  • Discussion points/discussion only

Documentation, Websites and Public Information

  • Documentation Work Group (15 min - Teri Sippel Schmidt)
  • NameSpace White paper comments due Nov 15th
  • Change in strategy for adoption of new Templates (see summary below) (Teri Sippel - 10 min)
  • FDA standards gathering initiative update (10 min - all)

Documentation Workgroup Revised Plan: (This will be documented on the DCC wiki page, but is presented here for discussion.)

Problem Stmt: Trying to adopt all of the templates simultaneously is too aggressive and not all of the material is currently ready.

A.) We recognize that the following items will not be ready:

    • 1. The NameSpace system will not be completed in time for the next round of supplement development.
    • 2. The Content Module Supplement (Section Z) will not be completed in time for the next round of supplement development.
    • 3. Possibly the General Introduction Appendix E (Profiling) and Appendix F (Integration Statements) may not be completed.

B.) We propose the following adoption process:

    • 1. Beginning January, 2012, any NEW Supplements will use the new Supplement Template (except for Content Module section, see C.3).
    • 2. Beginning January, 2012, any new Technical Framework will use the new Vol 1-4 templates (except for Content Module section, see C.3).
    • 3. The General Intro (aka Vol 0) will be published on the web and referencable (except Appendix E and F, see A.3). Volume 0 will be updated as new Supplements are moved to Trial Implementation status. The process for this is TBA.

C.) Proposed way forward includes:

    • 1. Existing Supplements do not need to be converted in this cycle, but conversion work can begin if desired.
    • 2. Existing Technical Frameworks do not need to be converted in this cycle, but conversion work can begin if desired.
    • 3. As a note, it is currently planned that the Content Module template will be partly based upon the Cardiology CIRC Profile.
    • 4. The timeframe for the required adoption of the new templates into existing published documents will be determined in the future.

Governance Implementation

Next steps and New Actions Items

  • Next Call Nov 22, 2011

Domain Coordination Committee